Analyse this. Many psychiatrists claim that children are undertreated for depression and ADHD, but critics charge abuse

EMBO Reports

Volumn 4, Issue 11, 2003, Pages 1022-1024

  Brower, Vicki ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CENTRAL NERVOUS SYSTEM AGENTS; FLUOXETINE; FLUVOXAMINE MALEATE; METHYLPHENIDATE; PAROXETINE; PENICILLIN G; SERTRALINE; UNCLASSIFIED DRUG; VENLAFAXINE; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ANTISOCIAL BEHAVIOR; ATTENTION DEFICIT DISORDER; CAUSE OF DEATH; CHILD; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MENTAL HEALTH SERVICE; NOTE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOTHERAPY; RISK BENEFIT ANALYSIS; SUBSTANCE ABUSE; SUICIDE; THOUGHT DISORDER; ARTICLE;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DEPRESSION; HUMANS; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 0348133613     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400022     Document Type: Note

References (4)

1. Santarelli, L. et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805-809.
2. Sheline, Y.I., Gado, M.H. & Kraemer, H.C. (2003) Untreated depression and hippocampal volume loss. Am. J. Psychiatry, 160, 1516-1518.
3. Treatment for Adolescents with Depression Study Team (2003) Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods. J. Am. Acad. Child Adolesc. Psychiatry, 42, 531-542.
4. Wagner, K.D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M.S., Childress, A., Donnelly, C. & Deas, D. (Sertraline Pediatric Depression Study Group) (2003) Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. J. Am. Med.